Miromatrix Medical Inc.

Clinical trials sponsored by Miromatrix Medical Inc., explained in plain language.

Now part of United Therapeutics Corporation UTHR NASDAQ

A regenerative medicine company developing bioengineered organs and tissues.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Completed 1

Artificial liver device tested in humans for first time

Disease control Completed

This early-stage trial tested a device called miroliverELAP, which uses a bioengineered liver graft to filter blood outside the body, in 10 adults with acute liver failure. The goal was to check safety and see if it can support the liver for up to 48 hours, giving time for recove…

Phase 1 • Sponsor: Miromatrix Medical Inc. • Aim: Disease control

Last updated Jun 27, 2026 09:10 UTC

Miromatrix Medical Inc.

Artificial liver device tested in humans for first time